List of Indian companies in Venezuela
Home › List of Indian companies in Venezuela
Untitled Document


ONGC Videsh Ltd. (OVL) 
Torre KPMG, 
Piso 3, Oficina # 3-2B, 
Av. Francisco de Miranda,
Chacao, Caracas
Tel: (+58) 212 2667318
Fax: (+58) 212 2638925


ONGC Videsh Ltd. (OVL), a Miniratna Schedule “A” Central Public Sector Enterprise (CPSE) of the Government of India under the administrative control of the Ministry of Petroleum & Natural Gas is the wholly owned subsidiary and overseas arm of Oil and Natural Gas Corporation Limited (ONGC), the flagship national oil company (NOC) of India. The primary business of OVL is to prospect for oil and gas acreages outside India, including exploration, development and production of oil and gas. OVL owns Participating Interests (PI) in 32 oil and gas assets in 16 countries and contributes to about 12% and 7 % of oil and natural gas production of India respectively. During FY’13, OVL produced 7.26 MMToe of equity oil & gas which was 11.5% of India’s crude production. As per ONGC Group’s Perspective Plan 2030, OVL’s oil and gas production should increase from the existing level of 7.26 MMToe to 20 MMToe by 2017-18 and 60 MMToe by 2029-30.

OVL has stake in 32 oil and gas projects in 16 Countries, viz. Vietnam (2 projects), Russia (2 projects), Sudan (2 projects), South Sudan (2 projects), Iran (1 project), Iraq (1 project), Libya (1 project), Myanmar (2 projects), Syria (2 projects), Cuba (1 project), Brazil (2 projects), Nigeria (1 project), Colombia (8 projects), Venezuela (2 projects), Kazakhstan (1 project) and Azerbaijan (2 projects). OVL had ventured into midstream and had successfully completed 741 Km product pipeline project in Sudan in 2005. In March 2013, it acquired 2.36% stake in the BTC pipeline as part of its acquisition of stake in Azerbaijan.

OVL has equity participation in 2 projects in Venezuela. OVL signed an agreement with Corporación Venezolana del Petróleo S.A. (CVP), a subsidiary of PDVSA on 8th April, 2008 and acquired 40% PI in San Cristobal Project, Venezuela. San Cristobal project covers an area of 160.18 Sq. Km in the Zuata Subdivision of proliferous Orinoco Heavy Oil belt in Venezuela. The JV Company is named “Petrolera Indovenezolana SA”. OVL along with Indian Oil Corporation Limited (IOC), Oil India Limited (OIL), Repsol YPF (Repsol) and Petroliam Nasional Berhad (PETRONAS) (collectively, the “Consortium”), was awarded by the Government of the Bolivarian Republic of Venezuela 40% ownership interest in an “Empresa Mixta” (or “Mixed Company") which will develop the Carabobo 1 North (203 and Carabobo 1 Central (180 blocks located in the Orinoco Heavy Oil Belt in eastern Venezuela. OVL holds 11% PI in Carabobo-1 project. The Mixed Company was incorporated as “Petro Carabobo S.A.” in 2010.

OVL has emerged as India’s most internationalized company based on the Transnationality Index (TNI) as per survey conducted jointly by Indian school of Business (ISB), Hyderabad and Fundacao Dom Cabral (FDC), Brazil. Fulfilling social responsibility as a corporate citizen is part of the foundational ethos of Indian Public Sector Enterprises. OVL is committed to create a positive and lasting social impact by developing successful partnerships built on mutual trust and respect, ultimately raising the standard of living and the stability of the communities of the countries in which the Company operates. OVL makes valuable contribution in many ways e.g. through payment of tax revenues to governments; by investing in education and training and improving employment opportunities for nationals; providing medical/ sports/ agricultural facilities to the local community, etc.

Oil India Limited 
Torre KPMG
Piso 3, Oficina # 3 – 2 B
Av. Fransisco de Miranda
Chacao, Caracas 1060, Venezuela

Tel: (+58) 212 - 2647454
Fax: (+58) 212 – 2638925


Oil India Limited (OIL) is a premier Indian National Oil Company engaged in the business of exploration, development and production of crude oil and natural gas, transportation of crude oil and production of LPG. It is the second largest hydrocarbon exploration & production (E&P;) Indian public sector company. The story of OIL traces and symbolises the development and growth of the Indian petroleum industry. From the discovery of crude oil in the far east of India at Digboi, Assam in 1889 to its present status as a fully integrated upstream petroleum company, OIL has come far, crossing many milestones. On February 18, 1959, Oil India Private Limited was incorporated to expand and develop the newly discovered oil fields of Naharkatiya and Moran in the Indian North East. In 1961, it became a joint venture company between the Indian Government and Burmah Oil Company Limited, UK. In 1981, OIL became a wholly-owned Government of India enterprise. Today, OIL also provides various E&P; related services and holds 26% equity in Numaligarh Refinery Limited.

Engineers India Limited, 
Torre KPMG, Piso 3, Oficina Nro 3-2B, 
Avenida Francisco de Miranda, 
Chacao, Caracas-1060, Venezuela 
Tel: +58-212-2679655


Engineers India Ltd (EIL) is one of the leading design and engineering organizations in South Asia. Established in 1965, EIL provides engineering consultancy and EPC services principally focused on the oil & gas and petrochemical industries. The Company has also diversified into sectors like infrastructure, water and waste management, solar & nuclear power and fertilizers to leverage its strong technical competencies and track record. Today, EIL is a ‘Total Solution’ engineering consultancy company providing design, engineering, procurement, construction and integrated project management services from ‘Concept to Commissioning’ with highest quality and safety standards. It also provides specialist services such as heat and mass transfer equipment design, environmental engineering, specialist materials and maintenance and plant operations and safety services.

Dr. Reddy's Laboratories Ltd. 
1501, Piso 15. 
Torre Humboldt, Av Rio Caura 
Prados del Este Caracas. 1080. 
Tel: 0058 212 9777378


Is a pharmaceutical company based in Hyderabad, Andhra Pradesh, India. The company was founded by Mr. Anji Reddy, who had previously worked in the publicly owned Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Reddy's had six FDA plants producing active pharmaceutical ingredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications – five of them in India and two in the UK. In 2010, the family-controlled Dr Reddy's denied[2] that it was in talks to sell its generics business in India to US pharmaceutical giant Pfizer,[3] which had been suing the company for alleged patent infringement after Dr Reddy's announced that it intended to produce a generic version of Atorvastatin, marketed by Pfizer as Lipitor, an anti-cholesterol medication.[4][5] Reddy's was already linked to UK pharmaceuticals multinational Glaxo Smithkline.

Sun Pharmaceutical Industries Limited 
ASPEN Venezuela , CA 
Av Francisco De Miranda, Altamira, Edif Torre Delta 
PISO - 10, Chacao, Caracas 1060, Venezuela. 
Tel: 0058 212 2619817 
Fax: 0058 2122612168


Is an Indian global pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) throughout the world. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances. Sun Pharmaceuticals was established by Mr. Dilip Shanghvi in 1983 in Kolkata with five products to treat psychiatry ailments. Cardiology products were introduced in 1987 followed by gastroenterology products in 1989. Today it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrology. Some of the top brands of the company include pantocid, susten, aztor, gemer, repace, glucored, strocit, clopilet and cardivas. Over 57% of Sun Pharma sales are from markets outside India, primarily in the US. Manufacturing is across 23 locations, including the US, Canada, Brazil, Mexico and Israel.